News

Moderna stock is indeed in the doldrums today, but this offers the opportunity to buy at a reasonable price, and, 10 years ...
Moderna has a deep pipeline of promising mRNA candidates that stand to boost business. Regeneron is looking at label ...
The company was pleased to report the findings of a late-stage clinical trial of its advanced flu vaccine. Moderna (NASDAQ: ...
The 24.4 metres long and 7.6 metre-tall fossil from the late Jurassic Period was 90 per cent original. Skeleton displays of ...